Skip to main content

Table 1 General characteristics of the patients and controls

From: Hypermethylation of DDAH2 promoter contributes to the dysfunction of endothelial progenitor cells in coronary artery disease patients

 

Control

CAD patients

P

 

(n = 15)

(n = 25)

 

Gender

  

0.7360

 Male (%)

10 (67.70)

18 (72.00)

 

 Female (%)

5 (32.30)

7 (28.00)

 

Age (years)

64.73 ± 3.00

67.36 ± 2.00

0.3469

BMI, kg/m2

23.10 ± 0.43

22.53 ± 0.37

0.3289

SBP, mm Hg

160.70 ± 4.00

161.00 ± 4.00

0.9438

DBP, mm Hg

91.40 ± 3.00

92.80 ± 3.00

0.8707

Creatinine, μmol/L

84.41 ± 6.17

109.6 ± 22.25

0.3943

Homocysteine, μmol/L

10.9400 ± .73

16.3400 ± 1.47

0.004

fasting blood-glucose (mmol/L)

7.06 ± 0.78

6.03 ± 0.40

0.1131

Triglyceride, ìmol/L

2.45 ± 0.48

1.97 ± 0.24

0.3320

Total cholesterol, ìmol/L

4.49 ± 0.24

4.53 ± 0.20

0.8967

LDL-C, mmol/L

2.65 ± 0.31

2.80 ± 0.43

0.8966

Positive history of diabetes (%)

5(40)

4(16)

0.2550

Positive history of smoking (%)

3(20)

9(36)

0.4770

Positive history of drinking (%)

3(20)

11(44)

0.1770